Roosevelt Investment Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,881
Closed -$2.58M 258
2021
Q1
$2.58M Sell
11,881
-116,004
-91% -$21.8M 0.17% 75
2020
Q4
$14.8M Buy
127,885
+32,386
+34% +$3.63M 1.05% 40
2020
Q3
$9.3M Buy
95,499
+3,330
+4% +$383K 0.75% 47
2020
Q2
$11.3M Sell
92,169
-18,148
-16% -$2.06M 1.12% 39
2020
Q1
$9.66M Buy
110,317
+5,483
+5% +$581K 1.11% 35
2019
Q4
$11M Buy
104,834
+36,815
+54% +$4.13M 1.13% 40
2019
Q3
$7.82M Buy
68,019
+324
+0.5% +$49.2K 0.89% 40
2019
Q2
$11.7M Buy
67,695
+2,697
+4% +$466K 1.37% 37
2019
Q1
$11M Buy
64,998
+42,716
+192% +$6.36M 1.36% 33
2018
Q4
$2.17M Sell
22,282
-772
-3% -$101K 0.24% 72
2018
Q3
$3.98M Buy
23,054
+91
+0.4% +$13.1K 0.36% 65
2018
Q2
$3.2M Buy
+22,963
New +$3.26M 0.3% 73

Other funds holding GWPH

Roosevelt Investment Group's GWPH Position: Q2 2021 in Review

Roosevelt Investment Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 11,881 shares — an estimated $2.58M sold.

Roosevelt Investment Group first reported a position in GWPH in Q2 2018 and held it in 12 quarters. The position peaked at $14.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Roosevelt Investment Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Roosevelt Investment Group sold 11,881 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.58M.
  • Roosevelt Investment Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 12 quarters.
  • Roosevelt Investment Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14.8M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Roosevelt Investment Group's 13F filing for Q2 2021, filed 11 Aug 2021.